Clinical Research Directory
Browse clinical research sites, groups, and studies.
Type 1 Diabetes Extension Study
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Summary
This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D). This observational study will: * follow participants to determine how long they continue to produce insulin, and * will also assess how changes in the immune system over time relate to the ability to produce insulin. This information could help design better therapies for type 1 diabetes in the future.
Key Details
Gender
All
Age Range
8 Years - 35 Years
Study Type
OBSERVATIONAL
Enrollment
111
Start Date
2016-08-18
Completion Date
2028-08
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Locations (12)
UCSF School of Medicine
San Francisco, California, United States
Stanford University
Stanford, California, United States
University of Colorado School of Medicine: Barbara Davis Center for Diabetes
Aurora, Colorado, United States
Yale University
New Haven, Connecticut, United States
Emory University
Atlanta, Georgia, United States
Indiana University Riley Hospital for Children
Indianapolis, Indiana, United States
University of Iowa Health Care Division of Pediatric Endocrinology
Iowa City, Iowa, United States
Joslin Diabetes Center
Boston, Massachusetts, United States
University of Minnesota
Minneapolis, Minnesota, United States
Children's Mercy Hospital
Kansas City, Missouri, United States
Sanford Research
Sioux Falls, South Dakota, United States
Benaroya Research Institute
Seattle, Washington, United States